Download the pieces below to access engaging summaries of peer-reviewed publications on ZOLGENSMA trials, safety data, and data from clinical practice. You may access the full article within each reprint.
Novartis Gene Therapies is offering the Novartis Gene Therapies Laboratory Program to assist with genetic and anti-AAV9 antibody testing. For more information, please contact your Novartis Gene Therapies Regional Account Associate Director or call the OneGene Program® at 1-855-441-GENE (4363)
Patient and caregiver support
Get support for you, your patients, and their families through the OneGene Program®
Patient advocacy groups
Patient advocacy organizations and other disease foundations can help caregivers and families contend with a new diagnosis, learn about SMA, and build meaningful connections.
Learn more about advocacy groups that support and educate families living with SMA at Novartis.com.